ENZYMES: Biochemistry, Biotechnology, Clinical Chemistry, 2nd ed. [Hardcover] [Jan 01, 2008] Trevor Palmer,Philip Bonner

(9)
ENZYMES: Biochemistry, Biotechnology, Clinical Chemistry, 2nd ed. [Hardcover] [Jan 01, 2008] Trevor Palmer,Philip Bonner image
ISBN-10:

8176710598

ISBN-13:

9788176710596

Edition: 2nd
Released: Jan 01, 2008
Format: Hardcover

Description:

Book details unavailable.

Best prices to buy, sell, or rent ISBN 9788176710596




Frequently Asked Questions about ENZYMES: Biochemistry, Biotechnology, Clinical Chemistry, 2nd ed. [Hardcover] [Jan 01, 2008] Trevor Palmer,Philip Bonner

You can buy the ENZYMES: Biochemistry, Biotechnology, Clinical Chemistry, 2nd ed. [Hardcover] [Jan 01, 2008] Trevor Palmer,Philip Bonner book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $27.05 on Amazon and is available from 7 sellers at the moment.

At BookScouter, the prices for the book start at $10.77. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.

If you’re interested in selling back the ENZYMES: Biochemistry, Biotechnology, Clinical Chemistry, 2nd ed. [Hardcover] [Jan 01, 2008] Trevor Palmer,Philip Bonner book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the ENZYMES: Biochemistry, Biotechnology, Clinical Chemistry, 2nd ed. [Hardcover] [Jan 01, 2008] Trevor Palmer,Philip Bonner book, the best buyback offer comes from and is $ for the book in good condition.

The ENZYMES: Biochemistry, Biotechnology, Clinical Chemistry, 2nd ed. [Hardcover] [Jan 01, 2008] Trevor Palmer,Philip Bonner book is in very low demand now as the rank for the book is 6,262,069 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.